FDA.reportPublic FDA data

MANNITOL

Substance profile for UNII 3OWL53L36A, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for MANNITOL
Structure render from NCI/CADD chemical resolver

Substance Identity#

UNII
3OWL53L36A
Preferred term
MANNITOL
Registry number
69-65-8
EC number
200-711-8
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C6H14O6
Chemical structure for MANNITOL
Structure render from NCI/CADD chemical resolver

Chemical And Database Identifiers#

InChIKey
FBPFZTCFMRRESA-KVTDHHQDSA-N
SMILES
OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
RxCUI
6628
PubChem
0
NCIt
C625
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem InChIKey SearchFBPFZTCFMRRESA-KVTDHHQDSA-Npubchem.ncbi.nlm.nih.gov/#query=FBPFZTCFMRRESA-KVTDHHQDSA-N
RxNorm6628mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=6628
NCI ThesaurusC625ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C625
FDA Substance Registration System3OWL53L36Aprecision.fda.gov/uniisearch/srs/unii/3OWL53L36A
European Community number200-711-8commonchemistry.cas.org/results?q=200-711-8

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
PANTOPRAZOLE SODIUM5
Eaudeleman Cosmetic Co.; Ltd3165
Eaudleman Cosmetic Co.; Ltd3163
CARVEDILOL - carvedilol tablet Sun Pharmaceutical Industries, Inc. These highlights do not include all the information needed to use Carvedilol Tablets safely and effectively. See full prescribing information for Carvedilol Tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 199513
These highlights do not include all the information needed to use donepezil hydrochloride orally disintegrating tablets USP safely and effectively. See full prescribing information for donepezil hydrochloride orally disintegrating tablets USP. DONEPEZIL hydrochloride orally disintegrating tablets, USP Initial U.S. Approval: 199631
LISINOPRIL TABLETS USP Rx only13
These highlights do not include all the information needed to use TRIGLIDE ® safely and effectively. See full prescribing information for TRIGLIDE. TRIGLIDE (fenofibrate) Tablets, for oral use Initial U.S. Approval: 199317
These highlights do not include all the information needed to use PANTOPRAZOLE sodium delayed-release tablets, USP safely and effectively. See full prescribing information for PANTOPRAZOLE sodium delayed-release tablets, USP. PANTOPRAZOLE sodium delayed-release tablets, USP, for oral administration Initial U.S. approval: 200011
These highlights do not include all the information needed to use AMLODIPINE and VALSARTAN safely and effectively. See full prescribing information for AMLODIPINE and VALSARTAN. AMLODIPINE and VALSARTAN (AMLODIPINE and VALSARTAN) TABLET for ORAL use. Initial U.S. Approval: 20075
These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP . OMEPRAZOLE Delayed-Release Capsules, USP , for oral use INITIAL U.S. APPROVAL: 198915
These highlights do not include all the information needed to use RECOTHROM safely and effectively. See full prescribing information for RECOTHROM. RECOTHROM, Thrombin topical (Recombinant) Lyophilized Powder for Solution - For Topical Use Only Initial U.S. Approval: 20088
LISINOPRIL TABLETS, USP Rx only18
LISINOPRIL TABLETS, USP Rx only18
These highlights do not include all the information needed to use gemcitabine for injection safely and effectively. See full prescribing information for gemcitabine for injection. Gemcitabine For Injection, Powder, Lyophilized, For Solution For Intravenous Use Initial U.S. Approval: 19965
These highlights do not include all the information needed to use montelukast sodium safely and effectively. See full prescribing information for montelukast sodium. Montelukast Sodium Tablets and Montelukast Sodium Chewable Tablets Initial U.S. Approval:19981001
These highlights do not include all the information needed to use Escitalopram Tablets USP safely and effectively. See full prescribing information for Escitalopram Tablets USP. Initial U.S. Approval: 20025
These highlights do not include all the information needed to use VIBATIV ® (telavancin) safely and effectively. See full prescribing information for VIBATIV. VIBATIV ® (telavancin) for injection, for intravenous use Initial U.S. Approval: 20099
Childrens Allegra Allergy-ODT12
215516de-ed61-4b68-bf61-db15fa4f76cf10
LISINOPRIL and HYDROCHLOROTHIAZIDE TABLETS, USP6
GABAPENTIN CAPSULES, USP 40-9155 Revised — September 2011 Rx only27
40-9165 Revised-October 2011 Rx only14
LISINOPRIL TABLETS USP Once-Daily Rx only10
Rx Only7
These highlights do not include all the information needed to use SAPHRIS (asenapine) safely and effectively. See full prescribing information for SAPHRIS. SAPHRIS ® (asenapine) sublingual tablets Initial U.S. Approval: 200916
Lisinopril and Hydrochlorothiazide13
Lisinopril Tablets12
These highlights do not include all the information needed to use SINGULAIR safely and effectively. See full prescribing information for SINGULAIR. SINGULAIR ® (montelukast sodium) Tablets, Chewable Tablets, and Oral Granules Initial U.S. Approval: 19981000
LISINOPRIL and HYDROCHLOROTHIAZIDE TABLETS USP Rx only1000
These highlights do not include all the information needed to use SINGULAIR safely and effectively. See full prescribing information for SINGULAIR. SINGULAIR ® (montelukast sodium) Tablets, Chewable Tablets, and Oral Granules Initial U.S. Approval: 19981000
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP "Initial U.S. Approval:".19896
Lisinopril Tablets USP12
70015427 Diethylpropion HCl USP C-IV Immediate-Release 25 mg Tablets Diethylpropion HCl USP C-IV Controlled-Release 75 mg Tablets Rx only Rev. March 20077
Drug Facts17
2cfedf7a-8ec2-4060-a4cf-305c06e031927
Therapentin-9012
Lytensopril-90 2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg and 40 mg Rx only8
Lisinopril Tablets USP7
These highlights do not include all the information needed to use Fusilev safely and effectively. See full prescribing information for Fusilev. Fusilev ® (levoleucovorin) FOR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION for INTRAVENOUS use Fusilev ® (levoleucovorin) INJECTION, SOLUTION for INTRAVENOUS use Initial U.S. Approval: 1952 (d,l-leucovorin), 2008 (levoleucovorin)6
Buprenorphine hydrochloride 8mg1002
ONDANSETRON TABLET, ORALLY DISINTEGRATING [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3999
GABAPENTIN CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3975
LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3953
ONDANSETRON TABLET, ORALLY DISINTEGRATING [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3925
GABAPENTIN CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3890
SUBOXONE (BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3832
FEXOFENADINE HYDROCHLORIDE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3814
LISINOPRIL TABLET [LAKE ERIE MEDICAL QUALITY CARE PRODUCTS LLC]3711
SINGULAIR (MONTELUKAST SODIUM) TABLET, CHEWABLE SINGULAIR (MONTELUKAST SODIUM) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3686
ACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLIES DBA QUALITY CARE PRODUCTS LLC]3607
ACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUTCS LLC]3575
GABAPENTIN (GABAPENTIN ) CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3480
OMEPRAZOLE CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3379
PLAVIX (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3378
VENLAFAXINE HYDROCHLORIDE TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3320
GABAPENTIN CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3306
PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3263
GENE 16 WHITENING FACTOR (ALLANTOIN) TABLET, SOLUBLE [SHANGHAI LIANG LIANG INTERNATIONAL INC]3133
LISINOPRIL TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3055
HUMIRA (ADALIMUMAB) KIT HUMIRA (ADALIMUMAB) INJECTION, SOLUTION [ABBVIE INC.]1805
LUPRON DEPOT (LEUPROLIDE ACETATE) KIT [ABBVIE INC.]1488
LUPRON DEPOT (LEUPROLIDE ACETATE) KIT [ABBVIE INC.]1450
LUPRON DEPOT (LEUPROLIDE ACETATE) KIT [ABBVIE INC.]1447
SUBOXONE (BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE) TABLET [BRYANT RANCH PREPACK]1004
ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]1002
ACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [BRYANT RANCH PREPACK]1001
ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]1001
HYOSCYAMINE SULFATE TABLET [BRYANT RANCH PREPACK]1001
LISINOPRIL TABLET [BRYANT RANCH PREPACK]1001
LISINOPRIL TABLET [BRYANT RANCH PREPACK]1001
MIRTAZAPINE TABLET, ORALLY DISINTEGRATING [BRYANT RANCH PREPACK]1001
MONTELUKAST SODIUM TABLET, CHEWABLE [BRYANT RANCH PREPACK]1001
BRILINTA (TICAGRELOR) TABLET [BRYANT RANCH PREPACK]1000
BUPRENORPHINE HCL AND NALOXONE HCL (BUPRENORPHINE AND NALOXONE) TABLET [BRYANT RANCH PREPACK]1000
DULOXETINE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK]1000
DULOXETINE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK]1000
ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
FLUVOXAMINE MALEATE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
LANSOPRAZOLE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK]1000
MIRTAZAPINE TABLET, ORALLY DISINTEGRATING [BRYANT RANCH PREPACK]1000
MIRTAZAPINE TABLET, ORALLY DISINTEGRATING [BRYANT RANCH PREPACK]1000
MIRTAZAPINE TABLET, ORALLY DISINTEGRATING [BRYANT RANCH PREPACK]1000
PANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK]1000
PRAMIPEXOLE DIHYDROCHLORIDE TABLET [BRYANT RANCH PREPACK]1000
PRAMIPEXOLE DIHYDROCHLORIDE TABLET [BRYANT RANCH PREPACK]1000
PRAMIPEXOLE DIHYDROCHLORIDE TABLET [BRYANT RANCH PREPACK]1000
ONDANSETRON TABLET, ORALLY DISINTEGRATING [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]456
OMEPRAZOLE CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]430
MIRAPEX (PRAMIPEXOLE DIHYDROCHLORIDE) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]415
LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]347
ENBREL (ETANERCEPT) SOLUTION ENBREL (ETANERCEPT) KIT [IMMUNEX CORPORATION]165
BUPRENORPHINE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) TABLET [REMEDYREPACK INC. ]130
BUPRENORPHINE HYDROCHLORIDE TABLET [REMEDYREPACK INC. ]130
NPLATE (ROMIPLOSTIM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [AMGEN INC]124
LUPANETA PACK (LEUPROLIDE ACETATE AND NORETHINDRONE ACETATE) KIT [ABBVIE INC.]122
LISINOPRIL TABLET [REMEDYREPACK INC. ]83
LUPANETA PACK (LEUPROLIDE ACETATE AND NORETHINDRONE ACETATE) KIT [ABBVIE INC.]76
LISINOPRIL TABLET [REMEDYREPACK INC. ]74
ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED ISENTRESS (RALTEGRAVIR) TABLET, CHEWABLE ISENTRESS (RALTEGRAVIR) GRANULE, FOR SUSPENSION [MERCK SHARP & DOHME CORP.]49
SINGULAIR (MONTELUKAST SODIUM) GRANULE SINGULAIR (MONTELUKAST SODIUM) TABLET, CHEWABLE SINGULAIR (MONTELUKAST SODIUM) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.]48
ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]45
ALIMTA (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ELI LILLY AND COMPANY]43
TRELSTAR (TRIPTORELIN PAMOATE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION TRELSTAR (TRIPTORELIN PAMOATE) KIT [ACTAVIS PHARMA, INC.]40
LISINOPRIL TABLET [MAJOR PHARMACEUTICALS]37
LUPRON DEPOT-PED (LEUPROLIDE ACETATE) KIT [ABBVIE INC.]36
KUVAN (SAPROPTERIN DIHYDROCHLORIDE) TABLET KUVAN (SAPROPTERIN DIHYDROCHLORIDE) POWDER, FOR SOLUTION KUVAN (SAPROPTERIN DIHYDROCHLORIDE) POWDER, FOR SOLUTION [BIOMARIN PHARMACEUTICAL INC.]35
AFINITOR (EVEROLIMUS) TABLET AFINITOR DISPERZ (EVEROLIMUS) TABLET, FOR SUSPENSION [NOVARTIS PHARMACEUTICALS CORPORATION]34
FAZACLO (CLOZAPINE) TABLET, ORALLY DISINTEGRATING [JAZZ PHARMACEUTICALS, INC.]33
LISINOPRIL TABLET [INTERNATIONAL LABORATORIES, INC.]33
ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY]33
LISINOPRIL TABLET [EON LABS, INC.]32
SUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]31
LISINOPRIL TABLET [REMEDYREPACK INC. ]29
PRILOSEC (OMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE PRILOSEC (OMEPRAZOLE MAGNESIUM) GRANULE, DELAYED RELEASE [ASTRAZENECA LP]29
LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [INTERNATIONAL LABORATORIES, INC.]28
PREVACID (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE PREVACID SOLUTAB (LANSOPRAZOLE) TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]28
LISINOPRIL TABLET [WEST-WARD PHARMACEUTICAL CORP]27
LISINOPRIL TABLET [PD-RX PHARMACEUTICALS, INC.]26
PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) GRANULE, DELAYED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]26
SINGULAIR (MONTELUKAST SODIUM) TABLET, CHEWABLE [PD-RX PHARMACEUTICALS, INC.]26

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 3OWL53L36A page 1 of 1 · 65 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
MANNITOL3OWL53L36A87785GUM, CHEWINGBUCCAL891 mg
MANNITOL3OWL53L36A87785TABLETBUCCAL360 mg
MANNITOL3OWL53L36A87785INJECTIONINTRAMUSCULAR106.6 mg
MANNITOL3OWL53L36A87785INJECTION, POWDER, FOR SOLUTIONINTRAMUSCULAR300 mg
MANNITOL3OWL53L36A87785INJECTION, POWDER, FOR SUSPENSIONINTRAMUSCULAR164 mg
MANNITOL3OWL53L36A87785INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONINTRAMUSCULAR113 mg
MANNITOL3OWL53L36A87785INJECTION, SUSPENSIONINTRAMUSCULAR71 mg
MANNITOL3OWL53L36A87785INJECTION, SUSPENSION, EXTENDED RELEASEINTRAMUSCULAR105 mg
MANNITOL3OWL53L36A87785POWDER, FOR SUSPENSIONINTRAMUSCULAR6.75 %w/v
MANNITOL3OWL53L36A87785CONCENTRATEINTRAVENOUS220 mg
MANNITOL3OWL53L36A87785INJECTIONINTRAVENOUS15200 mg
MANNITOL3OWL53L36A87785INJECTION, POWDER, FOR SOLUTIONINTRAVENOUS980.4 mg
MANNITOL3OWL53L36A87785INJECTION, POWDER, FOR SUSPENSIONINTRAVENOUS181 mg
MANNITOL3OWL53L36A87785INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONINTRAVENOUS15400 mg
MANNITOL3OWL53L36A87785INJECTION, SOLUTIONINTRAVENOUS15400 mg
MANNITOL3OWL53L36A87785INJECTION, SUSPENSIONINTRAVENOUS2.5 %w/v
MANNITOL3OWL53L36A87785SOLUTIONINTRAVENOUS15400 mg
MANNITOL3OWL53L36A87785SOLUTION, CONCENTRATEINTRAVENOUS220 mg
MANNITOL3OWL53L36A87785SPRAYNASAL41.5 mg
MANNITOL3OWL53L36A87785GELOPHTHALMIC25 mg
MANNITOL3OWL53L36A87785SOLUTIONOPHTHALMIC4.7 %w/v
MANNITOL3OWL53L36A87785SOLUTION, GEL FORMING / DROPSOPHTHALMIC4 mg
MANNITOL3OWL53L36A87785SOLUTION, GEL FORMING, EXTENDED RELEASEOPHTHALMIC4.35 %w/w
MANNITOL3OWL53L36A87785SOLUTION/ DROPSOPHTHALMIC4.6 %w/v
MANNITOL3OWL53L36A87785SUSPENSIONOPHTHALMIC9 mg
MANNITOL3OWL53L36A87785SUSPENSION/ DROPSOPHTHALMIC3.3 %w/v
MANNITOL3OWL53L36A87785CAPSULEORAL1562 mg
MANNITOL3OWL53L36A87785CAPSULE, COATED PELLETSORAL14 mg
MANNITOL3OWL53L36A87785CAPSULE, COATED, EXTENDED RELEASEORALNA
MANNITOL3OWL53L36A87785CAPSULE, DELAYED RELEASEORAL2043 mg
MANNITOL3OWL53L36A87785CAPSULE, EXTENDED RELEASEORAL160 mg
MANNITOL3OWL53L36A87785GRANULEORAL1328 mg
MANNITOL3OWL53L36A87785GRANULE, FOR SUSPENSIONORAL6000 mg
MANNITOL3OWL53L36A87785LOZENGEORAL20546 mg
MANNITOL3OWL53L36A87785POWDERORAL4352 mg
MANNITOL3OWL53L36A87785POWDER, FOR SOLUTIONORAL3767 mg
MANNITOL3OWL53L36A87785POWDER, FOR SUSPENSIONORAL7093 mg
MANNITOL3OWL53L36A87785SOLUTIONORAL869 mg
MANNITOL3OWL53L36A87785SUSPENSION, EXTENDED RELEASEORAL2464.6 mg
MANNITOL3OWL53L36A87785TABLETORAL3391 mg
MANNITOL3OWL53L36A87785TABLET, CHEWABLEORAL3726 mg
MANNITOL3OWL53L36A87785TABLET, CHEWABLE, EXTENDED RELEASEORAL616 mg
MANNITOL3OWL53L36A87785TABLET, COATEDORAL177.7 mg
MANNITOL3OWL53L36A87785TABLET, DELAYED RELEASEORAL639 mg
MANNITOL3OWL53L36A87785TABLET, EXTENDED RELEASEORAL1086 mg
MANNITOL3OWL53L36A87785TABLET, FILM COATEDORAL2309 mg
MANNITOL3OWL53L36A87785TABLET, FILM COATED, EXTENDED RELEASEORAL543 mg
MANNITOL3OWL53L36A87785TABLET, FOR SUSPENSIONORAL7621 mg
MANNITOL3OWL53L36A87785TABLET, ORALLY DISINTEGRATINGORAL4364 mg
MANNITOL3OWL53L36A87785TABLET, ORALLY DISINTEGRATING, DELAYED RELEASEORAL1568 mg
MANNITOL3OWL53L36A87785TROCHEORAL14594 mg
MANNITOL3OWL53L36A87785WAFERORAL642 mg
MANNITOL3OWL53L36A87785INJECTION, POWDER, FOR SOLUTIONPARENTERAL200 mg
MANNITOL3OWL53L36A87785POWDERRESPIRATORY (INHALATION)6 mg
MANNITOL3OWL53L36A87785INJECTIONSUBCUTANEOUS675 mg
MANNITOL3OWL53L36A87785INJECTION, POWDER, FOR SOLUTIONSUBCUTANEOUS35 mg
MANNITOL3OWL53L36A87785INJECTION, POWDER, FOR SUSPENSIONSUBCUTANEOUS180 mg
MANNITOL3OWL53L36A87785INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONSUBCUTANEOUS658 mg
MANNITOL3OWL53L36A87785INJECTION, SOLUTIONSUBCUTANEOUS99 mg
MANNITOL3OWL53L36A87785SOLUTIONSUBCUTANEOUS4.54 %w/v
MANNITOL3OWL53L36A87785TABLETSUBLINGUAL495 mg
MANNITOL3OWL53L36A87785TABLET, ORALLY DISINTEGRATINGSUBLINGUAL10.25 mg
MANNITOL3OWL53L36A87785INJECTION, SOLUTIONSUBMUCOSAL2.94 %w/v
MANNITOL3OWL53L36A87785SOLUTIONTOPICAL4 %w/v
MANNITOL3OWL53L36A87785SUSPENSION/ DROPSTOPICAL0.3 %w/v